Skip to main content
Clinical Trials/EUCTR2017-001189-98-DK
EUCTR2017-001189-98-DK
Active, not recruiting
Phase 1

eoadjuvant short-term Intensive Chemoresection versus Standard Adjuvant intravesical instillations in NMIBC - A study on effect and tolerability of neoadjuvant short-term intensive chemoresection and molecular markers for prediction of chemo-response - NICSA

Aarhus Universitet0 sites120 target enrollmentJune 2, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with recurrent non-muscle invasive bladder cancer
Sponsor
Aarhus Universitet
Enrollment
120
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 2, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Known history of urothelial non\-invasive Ta\-tumour low\-grade or high\-grade.
  • \=18 years old
  • Mentally healthy individual
  • The ability to understand Danish orally and in writing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 120
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 120

Exclusion Criteria

  • Known history of invasive tumour of the bladder (T1\+)
  • Known history of CIS of the bladder
  • Previous BCG\-treatment within the last 24 months
  • Previous Mitomycin C\-treatment (except single\-shot postoperative instillation)
  • Known allergy or intolerance to Mitomycin C
  • Solid tumour with suspicions of invasion
  • Single tumour of more than 2 cm in diameter
  • Suspicion of CIS (positive cytology with high\-grade neoplastic cells combined with suspicious cystoscopy for flat lesions).
  • Small bladder volume (less than 100 ml) or incontinence
  • Acute cystitis

Outcomes

Primary Outcomes

Not specified

Similar Trials